CCP
NEO icon

Clough Capital Partners’s NeoGenomics NEO Stock Holding History

Clough Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-252,500
Closed -$876K – 214
2014
Q1 		$876K Buy
+252,500
New +$946K 0.03% 167

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Clough Capital Partners's NEO Position: Q2 2014 in Review

Clough Capital Partners sold out of NeoGenomics (NEO) in Q2 2014, closing a stake of 252,500 shares — an estimated $876K sold.

Clough Capital Partners first reported a position in NEO in Q1 2014 and held it in 1 quarter. The position peaked at $876K in Q1 2014. 69 funds tracked by Wall St. Rank hold NEO as of Q2 2014.

  • Clough Capital Partners reported no remaining NeoGenomics position as of Q2 2014 after selling out during the quarter.
  • Clough Capital Partners sold 252,500 NeoGenomics shares in Q2 2014, an estimated $876K.
  • Clough Capital Partners first reported a position in NeoGenomics in Q1 2014 and held it in 1 quarter.
  • Clough Capital Partners's NeoGenomics position peaked at $876K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2014.

Based on Clough Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.